Back
Biomarin Pharmaceutical Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.73 | Buy |
| 20-day SMA: | 65.69 | Sell |
| 50-day SMA: | 68.56 | Sell |
| 200-day SMA: | 81.05 | Sell |
| 8-day EMA: | 63.9 | Buy |
| 20-day EMA: | 65.57 | Sell |
| 50-day EMA: | 69.74 | Sell |
| 200-day EMA: | 79.39 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 38.59 | Sell |
| Chaikin Money Flow: | 518116 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.94 - 69.24) | Sell |
| Bollinger Bands (100): | (67.93 - 87.19) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 64.26 while BMRN 8-day simple moving average is 63.73, which is a Buy signal.
- The stock price of BMRN is 64.26 while Biomarin Pharmaceutical 20-day SMA is 65.69, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 68.56 while BMRN share price is 64.26, making it a Sell technically.
- BMRN stock price is 64.26 and Biomarin Pharmaceutical 200-day simple moving average is 81.05, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
12.25B
Price in USD:
64.26
Share Volume:
1.26M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
61.15
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 64.26 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 64.26 while BMRN 8-day exponential moving average is 63.90, which is a Buy signal.
- The stock price of BMRN is 64.26 while Biomarin Pharmaceutical 20-day EMA is 65.57, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 69.74 while BMRN share price is 64.26, making it a Sell technically.
- BMRN stock price is 64.26 and Biomarin Pharmaceutical 200-day simple moving average is 79.39, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -1.96, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 38.59, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (63.94 - 69.24), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (67.93 - 87.19), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.